Kasimir-Bauer, S., Bittner, A., König, L., Reiter, K., Keller, T., Kimmig, R., & Hoffmann, O. (2016). Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy. Breast Cancer Res.
Chicago Style CitationKasimir-Bauer, Sabine, Ann-Kathrin Bittner, Lisa König, Katharina Reiter, Thomas Keller, Rainer Kimmig, and Oliver Hoffmann. "Does Primary Neoadjuvant Systemic Therapy Eradicate Minimal Residual Disease? Analysis of Disseminated and Circulating Tumor Cells Before and After Therapy." Breast Cancer Res 2016.
MLA CitationKasimir-Bauer, Sabine, et al. "Does Primary Neoadjuvant Systemic Therapy Eradicate Minimal Residual Disease? Analysis of Disseminated and Circulating Tumor Cells Before and After Therapy." Breast Cancer Res 2016.